Rituximab as Treatment for Refractory Kidney Transplant Rejection
Top Cited Papers
Open Access
- 2 April 2004
- journal article
- Published by Elsevier in American Journal of Transplantation
- Vol. 4 (6) , 996-1001
- https://doi.org/10.1111/j.1600-6143.2004.00454.x
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Molecular Heterogeneity in Acute Renal Allograft Rejection Identified by DNA Microarray ProfilingNew England Journal of Medicine, 2003
- Antibody-Mediated Rejection Criteria - an Addition to the Banff ’97 Classification of Renal Allograft RejectionAmerican Journal of Transplantation, 2003
- Utility of Intravenous Immune Globulin in Kidney Transplantation: Efficacy, Safety, and Cost ImplicationsAmerican Journal of Transplantation, 2003
- ACUTE HUMORAL REJECTION IN RENAL ALLOGRAFT RECIPIENTS: I. INCIDENCE, SEROLOGY AND CLINICAL CHARACTERISTICS1Transplantation, 2001
- Steroid-Resistant Kidney Transplant RejectionJournal of the American Society of Nephrology, 2001
- PLASMAPHERESIS AND INTRAVENOUS IMMUNE GLOBULIN PROVIDES EFFECTIVE RESCUE THERAPY FOR REFRACTORY HUMORAL REJECTION AND ALLOWS KIDNEYS TO BE SUCCESSFULLY TRANSPLANTED INTO CROSS-MATCH-POSITIVE RECIPIENTSTransplantation, 2000
- TREATMENT OF STEROID RESISTANT REJECTION WITH A NOVEL ANTI B-CELL PREPARATION, RITUXIMAB.Transplantation, 2000
- The Banff 97 working classification of renal allograft pathologyKidney International, 1999
- PRETRANSPLANT PLASMA EXCHANGE OR IMMUNOADSORPTION FACILITATES RENAL TRANSPLANTATION IN IMMUNIZED PATIENTSTransplantation, 1995
- Role of humoral presensitization in human renal transplant rejectionKidney International, 1980